Mainz Biomed NV
General ticker "MYNZ" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $97.5M
Mainz Biomed NV follows the US Stock Market performance with the rate: 23.7%.
Estimated limits based on current volatility of 13.6%: low 4.69$, high 6.16$
Factors to consider:
- Earnings expected soon, date: 2024-12-26 bmo
- Current price 166.4% above estimated high
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [0.48$, 1.86$]
- 2024-12-30 to 2025-12-30 estimated range: [0.42$, 1.41$]
Financial Metrics affecting the MYNZ estimates:
- Negative: Non-GAAP EPS, $ of -1.80 <= 0.10
- Negative: Operating profit margin, % of -96.75 <= 1.03
- Negative: negative Net income
- Negative: Operating cash flow per share per price, % of -54.09 <= 2.35
- Negative: Industry earnings per price (median), % of -26.04 <= 1.31
Short-term MYNZ quotes
Long-term MYNZ plot with estimates
Financial data
YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|
Operating Revenue | $0.58MM | $0.53MM | $0.90MM |
Operating Expenses | $9.96MM | $26.70MM | $27.54MM |
Operating Income | $-9.38MM | $-26.17MM | $-26.64MM |
Non-Operating Income | $-2.32MM | $-0.21MM | $0.35MM |
Interest Expense | $0.34MM | $0.29MM | $0.81MM |
R&D Expense | $0.47MM | $3.66MM | $9.59MM |
Income(Loss) | $-11.70MM | $-26.39MM | $-26.30MM |
Taxes | $0.38MM | $0.07MM | $0.00MM |
Profit(Loss) | $-12.07MM | $-26.45MM | $-26.30MM |
Stockholders Equity | $6.36MM | $14.10MM | $3.25MM |
Assets | $10.04MM | $20.24MM | $15.41MM |
Operating Cash Flow | $-3.22MM | $-14.77MM | $-21.94MM |
Capital expenditure | $0.02MM | $0.66MM | $1.90MM |
Investing Cash Flow | $1.20MM | $-0.66MM | $-1.90MM |
Financing Cash Flow | $10.61MM | $23.94MM | $14.23MM |
Earnings Per Share* | $-1.67 | $-1.87 | $-1.62 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.